Advertisement

Topics

Latest "Kiwanis International" News Stories - Page: 4

11:13 EDT 26th April 2018 | BioPortfolio

Here are the most relevant search results for "Kiwanis International" found in our extensive news archives from over 250 global news sources.

More Information about Kiwanis International on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about Kiwanis International for you to read. Along with our medical data and news we also list Kiwanis International Clinical Trials, which are updated daily. BioPortfolio also has a large database of Kiwanis International Companies for you to search.

Showing "Kiwanis International" News Articles 76–100 of 12,000+

Tuesday 24th April 2018

Who (really) wants gaydar to be accurate anyway?

(University of Surrey) Heterosexual men want their sexuality to be known when meeting someone for the first time more than any other sexual orientation group, a new study in the Journal of the International Society for the Study of Individual Differences, reports.


Dyadic International to Announce First Quarter 2018 Financial Results and Host Conference Call on Thursday May 10, 2018

JUPITER, Fla., April 25, 2018 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”) (OTCQX:DYAI), a global biotechnology company focused on further improving and applying its proprietary C1 expression system to help speed up the development and production of biologic vaccines and drugs at flexible commercial scales, announced today that it will report its financial results for the qua...

Skewed sex ratios causes single fathers to bring up the young

(University of Bath) When the balance of the sexes is skewed towards one gender, parents are more likely to split up, leaving the father to care for the offspring, says a study from an international team of scientists studying bird populations.


20152023 World Polyisobutylene PIB CAS 9003274 Market Research Report by Product Type, EndUser / Application and Regions / Countries [Report Updated: 23022018] Prices from USD $2800

SummaryThis report includes market status and forecast of global and major regions, with introduction of vendors, regions, product types and end industries; and this report counts product types and end industries in global and major regions.Market Segment as follows:By Region / Countries North America U.S., Canada, Mexico Europe Germany, U.K., France, Italy, Russia, Spain etc South Americ...

American Renal Associates Holdings, Inc. Announces First Quarter 2018 Earnings Release Date and Conference Call

American Renal Associates Holdings, Inc. (NYSE: ARA), a leading provider of dialysis services, announced today that it will release its first quarter 2018 financial results after the market close on Tuesday, May 8, 2018, to be followed by a conference call on Wednesday, May 9, 2018 at 9:00 a.m. (Eastern Time). The conference call can be accessed l...

Department of Culture and Tourism - Abu Dhabi Commemorates Late Sheikh Zayed at Zayed International Charity Marathon in New York

The Department of Culture and Tourism - Abu Dhabi (DCT Abu Dhabi) is organizing cultural and heritage activities as part of the 14th Zayed International Charity Marathon, ‘UAE Healthy Kidney 10K’, to be held at Central Park in New York on April 29, 2018. The marathon is held in memory of the late Sheikh Zayed bin Sultan Al Nahyan, the founding...

Clovis Oncology to Announce First Quarter 2018 Financial Results and Host Webcast Conference Call on May 8

Clovis Oncology, Inc. (NASDAQ: CLVS) will announce its first quarter 2018 financial results on Tuesday, May 8, 2018, after the close of the U.S. financial markets. Clovis’ senior management will host a conference call and live audio webcast at 4:30 p.m. ET to discuss the company’s results in greater detail. The conference call is being webcast...

Revance Therapeutics to Release First Quarter 2018 Financial Results on Tuesday, May 8, 2018

-Conference Call Scheduled for Tuesday, May 8, 2018 at 4:30pm ET- Revance Therapeutics, Inc. (NASDAQ:RVNC), a biotechnology company developing neuromodulators for use in treating aesthetic and therapeutic conditions, today announced that the Company will release first quarter 2018 financial results on Tuesday, May 8, 2018 after the close of market. Rev...

Jamieson Wellness Inc. Announces Date of First Quarter 2018 Financial Results and Conference Call

Jamieson Wellness Inc. ("Jamieson Wellness" or the "Company") (TSX:JWEL) announced today that the Company will release its first quarter 2018 financial results after the market close on Wednesday, May 9, 2018. The Company will host a conference call for investors at 5:00 p.m. Eastern Time to discuss the first quarter 2018 results. The call can be ...

Five Prime Therapeutics to Announce First Quarter 2018 Financial Results and Host Conference Call on May 8

Five Prime Therapeutics, Inc. (NASDAQ: FPRX), a clinical-stage biotechnology company focused on discovering and developing innovative immuno-oncology protein therapeutics, will report its first quarter 2018 financial results on Tuesday, May 8, 2018, after the U.S. financial markets close. Five Prime will host a conference call and liv

Sandoz to commercialize Pear's reSET digital therapeutics to combat substance abuse

Sandoz International GMBH will lead the commercialization of Pear Therapeutics Inc.'s reSET for substance use disorder (SUD) ...

Global and China Nylon 6/6 Market Research by Company, Type Application 20132025 [Report Updated: 08032018] Prices from USD $2000

SummaryMarket Segment as follows:By Type Upper GIT Lower GITBy Application Electronics Electrical Automotives Machinery Equipment Packaging Consumer Goods OthersBy Company Honeywell International LIBOLON Rhodia BASF Royal DSM SABIC Ube Industries Evonik Industries DuPont Radici Group Lanxess INVISTA Asahi Kasei Corporation EMSGRIV...

Zerhouni Retires, Sanofi's New R&D Chief John Reed Brings Early Research Experience From Roche

Sanofi's longtime head of R&D Elias Zerhouni will step down in July. He was a steady hand at Sanofi amid...   

News Release: Essilor 2018 Annual General Meeting

 Essilor 2018 Annual General Meeting PDF Version of the news release Adoption of all resolutions Dividend payment of €1.53 per share, up for the 25th consecutive year Charenton-le-Pont, France (April 24, 2018) - Essilor International's Annual General Meeting was held today at the Maison de la Mutualité in Paris, chaired by Hubert Sagnières, the Group's C...

Lilly Rides To Solid First Quarter On Diabetes, Newer Products

Smarting from a disappointing advisory committee review for baricitinib, Lilly pointed to the strong first quarter performance of its drugs...   

FDAnews Announces: The West Coast Symposium on Expanded Access, May 10, 2018, San Francisco, CA

Integrating expanded access into the drug and device development process could usher in a new era in FDA regulation. Find out more at The West Coast Symposium on Expanded Access, May 10, 2018 in San Francisco. FALLS CHURCH, Va. (PRWEB) April 24, 2018 The West Coast Symposium on Expanded Access Building Expanded Access into the Clinical Development Process **Presented by FDAnews** May 10, 2018 ...

Studies provide advanced knowledge about renal cancer

Cell, the most prestigious international journal in the field of biology, is today publishing a set of three papers on renal cancer. Among the authors of these papers is Dr José Ignacio López, head of the Pathological Anatomy Service of University Hospital Cruces and tenured lecturer in Pathological Anatomy at the UPV/EHU's Faculty of Medicine and Nursing.

NatureWorks Names Richard Altice New President and CEO

Altice joins company as it continues market-leading growth and innovation. NatureWorks’ board of directors named Richard Altice as the company’s new President and Chief Executive Officer, replacing Marc Verbruggen, who led the company from 2008 to his retirement in 2017. Altice comes to NatureWorks from PolyOne Corporation where he ...

BioKansas to Host the 2018 Kansas BioGENEius Challenge Finals on Thursday, April 26th

BioKansas is hosting the 2018 Kansas BioGENEius Challenge Finals this Thursday, April 26th, at Aratana Therapeutics, 11400 Tomahawk Creek Parkway, Leawood, Kansas, 66211. BioKansas has selected the best and brightest students from the Kansas State Science & Engineering Fair and the Greater Kansas City Science & Engineering Fair for the chance to co...

BIO Statement on Opioid Crisis Response Act of 2018

BIO President and CEO Jim Greenwood issued the following statement today regarding S. 2680, the Opioid Crisis Response Act of 2018: “BIO and our member companies are committed to unleashing the power of scientific innovation to develop solutions that will allow for an America free of prescription opioid addiction. I applaud Chairman Alexander an...

Moss polysaccharide has potential medical uses

An international team of scientists has discovered that a polysaccharide in physcomitrella patens moss has possible medicinal uses. The team,...Read More... The post Moss polysaccharide has potential medical uses appeared first on Drug Development Technology.

Ligand to Report First Quarter 2018 Results on May 8th

Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) announced today plans to report first quarter 2018 financial results on May 8, 2018. Ligand’s CEO John Higgins, President and COO Matt Foehr and Executive Vice President and CFO Matt Korenberg will host the conference call. First Quarter 2018 Earnings Call Wha...

RECCE PHARMACEUTICALS LTD - Pharmaceutical Expert Joins Board of Directors

SYDNEY, Australia - 24 April 2018 - Recce Pharmaceuticals Ltd (ASX: RCE) (Recce or the Company), developing a new class of synthetic antibiotics, today announced the appointment of Dr John Prendergast to its Board as an independent Non-Executive Director. Dr Prendergast brings significant international experience in commercialising pharmaceuticals for global markets, most notably in the USA...

BioScience Mangers: Downing FOUR VCT invests £1.14 million in ADC Biotechnology Ltd

Investment from Downing FOUR VCT (Healthcare and General share classes) advised by BioScience Managers Limited Funds used to progress development of Antibody Drug Conjugate (ADCs) technology Downing FOUR VCT is targeting dividends of at least 4% p.a. (of net assets) from the fourth year onwards* London, UK, 23 April 2018 – London-based investment management firm, Downing LLP,...

Enanta Pharmaceuticals to Host Conference Call on May 8 at 4:30 p.m. ET to Discuss Financial Results for its Fiscal Second Quarter Ended March 31, 2018

Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA), a research and development-focused biotechnology company dedicated to creating small molecule drugs for viral infections and liver diseases, today announced that it plans to report its financial results for its fiscal second quarter ended March 31, 2018, after the U.S. markets close on May 8, 2018. Enanta managem...


Advertisement
Quick Search
Advertisement
Advertisement

 

News Quicklinks